Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis

Ähnliche Einträge

• New strategies for the in vivo regulation of metalloprotease gene expression in osteoarthritis chondrocytes by inflammatory mediators
  von: Pelletier, JP, et al.
  Veröffentlicht: (2003)
• PD‐0200347, an α(2)δ ligand of the voltage gated calcium channel, inhibits in vivo activation of the Erk1/2 pathway in osteoarthritic chondrocytes: a PKCα dependent effect
  von: Boileau, C, et al.
  Veröffentlicht: (2006)
• The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.
  von: Reboul, P, et al.
  Veröffentlicht: (1996)
• Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis
  von: Tat, Steeve Kwan, et al.
  Veröffentlicht: (2009)
• Protective effects of total fraction of avocado/soybean unsaponifiables on the structural changes in experimental dog osteoarthritis: inhibition of nitric oxide synthase and matrix metalloproteinase-13
  von: Boileau, Christelle, et al.
  Veröffentlicht: (2009)